UBS O'Connor’s Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant NGC.U Stock Holding History

UBS O'Connor’s Portfolio NGC.U Stock Details NGC.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-204,113	Closed	-$2.04M	–	998
2021 Q1	$2.04M	Buy	+204,113	New	+$2.03M	0.03%	464

Other funds holding NGC.U

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

MAM

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS O'Connor's NGC.U Position: Q2 2021 in Review

UBS O'Connor sold out of Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant (NGC.U) in Q2 2021, closing a stake of 204,113 shares — an estimated $2.04M sold.

UBS O'Connor first reported a position in NGC.U in Q1 2021 and held it in 1 quarter. The position peaked at $2.04M in Q1 2021. 26 funds tracked by Wall St. Rank hold NGC.U as of Q2 2021.

UBS O'Connor reported no remaining Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
UBS O'Connor sold 204,113 Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant shares in Q2 2021, an estimated $2.04M.
UBS O'Connor first reported a position in Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 1 quarter.
UBS O'Connor's Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant position peaked at $2.04M in Q1 2021.
26 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.